FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2091235167> ?p ?o ?g. }

• W2091235167 endingPage "292" @default.
• W2091235167 startingPage "283" @default.
• W2091235167 abstract "In a phase I/II study, 11 patients with marrow failure (10 with acquired aplastic anaemia and one with pancytopenic Fanconi anaemia) were treated with recombinant human interleukin-6 (rhIL-6) to assess the safety and tolerability of rhIL-6 and its effects on peripheral blood counts, bleeding complications and transfusion requirements. All patients with acquired aplastic anaemia were refractory to immunosuppressive treatment or had relapsed after immunosuppressive therapy and were not bone marrow transplantation candidates. Recombinant hIL-6 was to be given as a once-daily subcutaneous injection for 28 d at doses ranging from 0.5 to 5.0 micrograms/kg. After an observation period of 2 weeks, five patients received a second treatment course of 28 d. Only one patient had a sustained increase in platelet count from 18,000 to 72,000/microliters. Bleeding occurred in four patients and caused premature discontinuation of rhIL-6 therapy in three patients. A deterioration of pre-existing anaemia was observed in nine patients. No significant changes of leucocyte counts were observed during the first cycle. During the second cycle the peripheral blood monocyte counts decreased significantly. No significant changes in bone marrow cellularity were observed. Recombinant hIL-6 induced a dose-dependent increase in acute-phase reactants in all patients. Other adverse events included fever, headache, arthralgia, tachycardia and hypertension. In conclusion, rhIL-6 given alone at low doses does not increase platelet counts in the majority of patients with aplastic anaemia and can precipitate a sudden worsening of pre-existing anaemia and thrombocytopenia. This study was discontinued prematurely on account of the toxicity of rhIL-6 seen in patients with aplastic anaemia." @default.
• W2091235167 created "2016-06-24" @default.
• W2091235167 creator A5003253888 @default.
• W2091235167 creator A5026724408 @default.
• W2091235167 creator A5041803179 @default.
• W2091235167 creator A5062964546 @default.
• W2091235167 creator A5064511387 @default.
• W2091235167 creator A5067841095 @default.
• W2091235167 creator A5068469918 @default.
• W2091235167 date "1995-06-01" @default.
• W2091235167 modified "2023-09-26" @default.
• W2091235167 title "A phase I/II trial of recombinant human interleukin-6 in patients with aplastic anaemia" @default.
• W2091235167 cites W15002790 @default.
• W2091235167 cites W1825082566 @default.
• W2091235167 cites W1965375035 @default.
• W2091235167 cites W1974486772 @default.
• W2091235167 cites W1976133490 @default.
• W2091235167 cites W1983612778 @default.
• W2091235167 cites W1998972086 @default.
• W2091235167 cites W2004650098 @default.
• W2091235167 cites W2038818733 @default.
• W2091235167 cites W2040996827 @default.
• W2091235167 cites W2042634606 @default.
• W2091235167 cites W2050243922 @default.
• W2091235167 cites W2054663403 @default.
• W2091235167 cites W2055482423 @default.
• W2091235167 cites W2064632541 @default.
• W2091235167 cites W2074672006 @default.
• W2091235167 cites W2078616156 @default.
• W2091235167 cites W2087568857 @default.
• W2091235167 cites W2089210688 @default.
• W2091235167 cites W2114438682 @default.
• W2091235167 cites W2122676446 @default.
• W2091235167 cites W2138040687 @default.
• W2091235167 cites W2153912609 @default.
• W2091235167 cites W2241219494 @default.
• W2091235167 cites W2256577232 @default.
• W2091235167 cites W2263914605 @default.
• W2091235167 cites W2265969331 @default.
• W2091235167 cites W2269012571 @default.
• W2091235167 cites W2287680939 @default.
• W2091235167 cites W2298584763 @default.
• W2091235167 cites W2326695376 @default.
• W2091235167 cites W2339498071 @default.
• W2091235167 cites W2340652822 @default.
• W2091235167 cites W2374798852 @default.
• W2091235167 cites W2399063565 @default.
• W2091235167 cites W2400790281 @default.
• W2091235167 cites W2408126077 @default.
• W2091235167 cites W2410946777 @default.
• W2091235167 cites W2413443307 @default.
• W2091235167 cites W2415098890 @default.
• W2091235167 cites W2419138996 @default.
• W2091235167 cites W320992867 @default.
• W2091235167 cites W336773932 @default.
• W2091235167 cites W343740181 @default.
• W2091235167 cites W79677368 @default.
• W2091235167 doi "https://doi.org/10.1111/j.1365-2141.1995.tb05148.x" @default.
• W2091235167 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7794747" @default.
• W2091235167 hasPublicationYear "1995" @default.
• W2091235167 type Work @default.
• W2091235167 sameAs 2091235167 @default.
• W2091235167 citedByCount "32" @default.
• W2091235167 countsByYear W20912351672014 @default.
• W2091235167 countsByYear W20912351672016 @default.
• W2091235167 countsByYear W20912351672019 @default.
• W2091235167 crossrefType "journal-article" @default.
• W2091235167 hasAuthorship W2091235167A5003253888 @default.
• W2091235167 hasAuthorship W2091235167A5026724408 @default.
• W2091235167 hasAuthorship W2091235167A5041803179 @default.
• W2091235167 hasAuthorship W2091235167A5062964546 @default.
• W2091235167 hasAuthorship W2091235167A5064511387 @default.
• W2091235167 hasAuthorship W2091235167A5067841095 @default.
• W2091235167 hasAuthorship W2091235167A5068469918 @default.
• W2091235167 hasConcept C126322002 @default.
• W2091235167 hasConcept C141071460 @default.
• W2091235167 hasConcept C197934379 @default.
• W2091235167 hasConcept C203014093 @default.
• W2091235167 hasConcept C2778375690 @default.
• W2091235167 hasConcept C2778715236 @default.
• W2091235167 hasConcept C2779382419 @default.
• W2091235167 hasConcept C2780007613 @default.
• W2091235167 hasConcept C71924100 @default.
• W2091235167 hasConcept C89560881 @default.
• W2091235167 hasConcept C90924648 @default.
• W2091235167 hasConceptScore W2091235167C126322002 @default.
• W2091235167 hasConceptScore W2091235167C141071460 @default.
• W2091235167 hasConceptScore W2091235167C197934379 @default.
• W2091235167 hasConceptScore W2091235167C203014093 @default.
• W2091235167 hasConceptScore W2091235167C2778375690 @default.
• W2091235167 hasConceptScore W2091235167C2778715236 @default.
• W2091235167 hasConceptScore W2091235167C2779382419 @default.
• W2091235167 hasConceptScore W2091235167C2780007613 @default.
• W2091235167 hasConceptScore W2091235167C71924100 @default.
• W2091235167 hasConceptScore W2091235167C89560881 @default.
• W2091235167 hasConceptScore W2091235167C90924648 @default.
• W2091235167 hasIssue "2" @default.
• W2091235167 hasLocation W20912351671 @default.

• next